In addition to providing FDA-inspected plants to develop new drugs, Hovione also offers proprietary product development and licensing opportunities for drug products.
The company relies on the knowledge and expertise that they have, meaning they have a lot of intellectual property that the need to protect, according to Joao Alvarinho, Hovione’s Director of IT.
“We work on drugs not yet in the market - so there’s a lot of need for confidentiality,” Joao said.
They recognized that usernames and passwords were not strong enough to protect access to their assets. While they are using many other security tools, they didn’t have a solution that could help them achieve stronger user authentication.
Easy to Deploy
Hovione uses Duo’s two-factor authentication company-wide across all of the countries they do business in, around 800 total users. That includes for users in their headquarters in Portugal, drug development plants in Ireland, Macau and China; and in an R&D facility in the U.S.
It took only a few weeks to roll out Duo by country. They chose Duo over its competitors because it was easy to use, rapid to deploy, and provided easy, out-of-the-box integrations. Hovione protects access to their webmail, terminal servers and Check Point VPN with Duo.
At Hovione, their administrators love Duo’s easy setup - Duo provides a number of different user enrollment options, including self-enrollment, bulk enrollment and Microsoft Entra ID sync for large enterprises. Hovione’s users also love Duo’s multiple authentication methods, including the Duo Mobile app, Duo Push, SMS, phone callback, U2F and more.
Duo’s trusted access solution gives healthcare companies an easy way to stay secure by verifying user identities with two-factor authentication and checking the security health of their devices before granting access to sensitive healthcare data, such as intellectual property. Learn about Duo for Healthcare.